383 related articles for article (PubMed ID: 19837286)
1. Francisella tularensis vaccines.
Oyston PC
Vaccine; 2009 Nov; 27 Suppl 4():D48-51. PubMed ID: 19837286
[TBL] [Abstract][Full Text] [Related]
2. Francisella tularensis vaccines.
Griffin KF; Oyston PC; Titball RW
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies for Francisella tularensis.
Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
5. Vaccines against Francisella tularensis.
Wayne Conlan J; Oyston PC
Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
[TBL] [Abstract][Full Text] [Related]
6. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
[No Abstract] [Full Text] [Related]
7. The tularaemia vaccine.
Sandström G
J Chem Technol Biotechnol; 1994 Apr; 59(4):315-20. PubMed ID: 7764815
[TBL] [Abstract][Full Text] [Related]
8. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated tularemia vaccines: recent developments and future goals.
Marohn ME; Barry EM
Vaccine; 2013 Aug; 31(35):3485-91. PubMed ID: 23764535
[TBL] [Abstract][Full Text] [Related]
10. Nature of protective immunity to Francisella tularensis.
Tärnvik A
Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
[TBL] [Abstract][Full Text] [Related]
11. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
[TBL] [Abstract][Full Text] [Related]
12. Tularemia vaccines: recent developments and remaining hurdles.
Conlan JW
Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Inner and Outer Membrane Proteins from
Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
[No Abstract] [Full Text] [Related]
14. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
[TBL] [Abstract][Full Text] [Related]
15. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.
Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI
Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723
[TBL] [Abstract][Full Text] [Related]
16. Tularemia: the disease and the weapon.
Cronquist SD
Dermatol Clin; 2004 Jul; 22(3):313-20, vi-vii. PubMed ID: 15207312
[TBL] [Abstract][Full Text] [Related]
17. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity.
Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA
Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.
Reed DS; Smith LP; Cole KS; Santiago AE; Mann BJ; Barry EM
Infect Immun; 2014 May; 82(5):2098-105. PubMed ID: 24614653
[TBL] [Abstract][Full Text] [Related]
19. Rationally designed tularemia vaccines.
Mann BJ; Ark NM
Expert Rev Vaccines; 2009 Jul; 8(7):877-85. PubMed ID: 19538114
[TBL] [Abstract][Full Text] [Related]
20. Biosafety and selectable markers.
Titball RW; Sjostedt A; Pavelka MS; Nano FE
Ann N Y Acad Sci; 2007 Jun; 1105():405-17. PubMed ID: 17416926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
